Cost-Effectiveness of Mobile Application Use in Managing Type 2 Diabetes Mellitus: A Systematic Review
Keywords:
Cost-effectiveness, Economic Burden, mHealth, Mobile Application, Type 2 Diabetes MellitusAbstract
Introduction:
Type 2 diabetes mellitus (T2DM) is a debilitating condition that imposes a significant economic burden on its management. This study aims to systematically review the published evidence on the cost-effectiveness of mobile health (mHealth) application interventions for T2DM.
Methods:
A search strategy was conducted using electronic bibliographic databases, including PubMed, Web of Science and Scopus for published studies. The inclusion criteria included original articles that reporting cost-effectiveness evaluation studies on mHealth application interventions directed at patients diagnosed or at risk of T2DM, English-language articles and published in the year 2016 to 2020
Results:
A total of 6 eligible studies were selected. The cost savings per person for treating T2DM ranged from USD 1,346 to USD 3,781 per year. The major contributor to cost savings was reduced complication management resulting from good glycaemic control. The direct impacts of the intervention include reduced hospitalisation and fewer unplanned clinic visits, while diabetes- related mortality was indirectly reduced using mHealth.
Conclusion:
The mHealth intervention was cost-effective in managing patients with T2DM. Implementation can be extended to other disease management areas to not only reduce total healthcare expenditure but also improve patients’ quality of life..
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Aliff Faisal Ahmad Kamar, Mohd Nazrin Jamhari, Noor Adilla Md Anuar Hussain, Shahrul Azhar Md Hanif, Fateen Nadhira Ismail, Norfazilah Ahmad, Mohd Ammar Ihsan Ahmad Zamzuri, Muhammad Fikri Azmi, Norayuni Ismail, Mohd Rohaizat Hassan
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
IJPHR applies the Creative Commons Attribution (CC BY) license to articles and other works we publish. If you submit your paper for publication by IJPHR, you agree to have the CC BY license applied to your work. Under this Open Access license, you as the author agree that anyone can reuse your article in whole or part for any purpose, for free, even for commercial purposes. Anyone may copy, distribute, or reuse the content as long as the author and original source are properly cited. This facilitates freedom in re-use and also ensures that IJPHR content can be mined without barriers for the needs of research.
